Stockreport

Mineralys Therapeutics (MLYS) Makes Progress With FDA For Hypertension [Yahoo! Finance]

Mineralys Therapeutics, Inc.  (MLYS) 
PDF Biopharmaceutical company Mineralys Therapeutics Inc. (NASDAQ:MLYS) scored a win on March 9th when it announced that the Food and Drug Administration (FDA) had accepted [Read more]